As President Trump prepares to announce pharmaceutical tariffs, he has one country, in particular, in his sights: Ireland.

exemplifies a process that could benefit from AI enhancements. The integration of AI into drug submission and approval processes is recognised as a pivotal force within the pharmaceutical industry.

Clinical pharmacoeconomics lead says one million people could benefit from weight loss drugs, but cost would be ‘unaffordable ...

STAT reporters chat about pharma tariffs, the latest recovery in biotech stocks, and disappointing data from a Bristol Myers Squibb drug.

Yet there was no access to them in Ireland under the HSE’s reimbursement system. The drug had been approved for a number of cancers by the EU regulator – the EMA – including, six months ...